Open access · CC-BY
via OpenAlex
Therapeutic Effect of Rapamycin on TDP-43-Related Pathogenesis in Ischemic Stroke
Yi‐Syue Tsou, Jing-Huei Lai, Kai‐Yun Chen, Cheng‐Fu Chang, Chi-Chen Sarah Huang
International Journal of Molecular Sciences · 2022 · ▲ 24 citations
Abstract
Stroke is a major cause of death and disability across the world, and its detrimental impact should not be underestimated. Therapies are available and effective for ischemic stroke (e.g., thrombolytic recanalization and mechanical thrombectomy); however, there are limitations to therapeutic interventions. Recanalization therapy has developed dramatically, while the use of adjunct neuroprotective agents as complementary therapies remains deficient. Pathological TAR DNA-binding protein (TDP-43) has been identified as a major component of insoluble aggregates in numerous neurodegenerative pathologies, including ALS, FTLD and Alzheimer's disease. Here, we show that increased pathological TDP-43 fractions accompanied by impaired mitochondrial function and increased gliosis were observed in an ischemic stroke rat model, suggesting a pathological role of TDP-43 in ischemic stroke. In ischemic rats administered mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), the insoluble TDP-43 fraction was significantly decreased in the ischemic cortex region, accompanied by a recovery of mitochondrial function, the attenuation of cellular apoptosis, a reduction in infarct areas and improvements in motor defects. Accordingly, our results suggest that rapamycin provides neuroprotective benefits not only by ameliorating pathological TDP-43 levels, but also by reversing mitochondrial function and attenuating cell apoptosis in ischemic stroke.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms24010676
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Tsou, Y., Lai, J., Chen, K., Chang, C., & Huang, C.S. (2022). Therapeutic Effect of Rapamycin on TDP-43-Related Pathogenesis in Ischemic Stroke. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms24010676
Vancouver
Tsou Y, Lai J, Chen K, Chang C, Huang CS. Therapeutic Effect of Rapamycin on TDP-43-Related Pathogenesis in Ischemic Stroke. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms24010676.
BibTeX
@article{yisyue2022Therap,
title = {Therapeutic Effect of Rapamycin on TDP-43-Related Pathogenesis in Ischemic Stroke},
author = {Yi‐Syue Tsou and Jing-Huei Lai and Kai‐Yun Chen and Cheng‐Fu Chang and Chi-Chen Sarah Huang},
journal = {International Journal of Molecular Sciences},
year = {2022},
doi = {10.3390/ijms24010676},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BioMed Research International 2014
Open access · CC-BY
Mitochondrial Dysfunctions in Neurodegenerative Diseases: Relevance to Alzheimer’s Disease
International Journal of Molecular Sciences 2024
Open access · CC-BY
Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
Aging and disease 2026
Citation only
Mitochondria Beyond Bioenergetics: Canonical and Non-Canonical Functions in Ischemic Stroke and Aging.
Biomedicines 2023
Open access · CC-BY
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Frontiers in Aging Neuroscience 2021
Open access · CC-BY
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Frontiers in Neuroscience 2020
Open access · CC-BY